March 20th, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
March 20th, 2018
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
March 16th, 2016
Sophisticated multimaterial printers and novel inks promise advances in electronic devices and bioengineering
March 7th, 2016
Bioprinting technique creates thick 3D tissues composed of human stem cells and embedded vasculature, with potential applications in drug testing and regenerative medicine.